Utah Medical Products (UTMD) EBT Margin (2010 - 2026)

Utah Medical Products' EBT Margin history runs 17 years deep, the most recent figure standing at 36.48% for Q1 2026.

• On a quarterly basis, EBT Margin fell 325.0% year-over-year to 36.48% in Q1 2026; TTM through Mar 2026 was 35.79%, a 460.0% decrease from a year earlier, with the FY2025 full-year figure at 36.63%, down 445.0% from the prior year.
• EBT Margin rose to 36.48% in Q1 2026 per UTMD's latest filing, from 34.34% in the prior quarter.
• Across five years, EBT Margin topped out at 42.31% in Q1 2024 and bottomed at 31.64% in Q4 2023.
• The 5-year median for EBT Margin is 39.47% (2024), against an average of 34.85%.
• Across the five-year window, EBT Margin jumped 9402 bps in 2022 and sank 7282 bps in 2023, its largest moves.
• Year by year, EBT Margin stood at 41.19% in 2022, then slumped by 177 bps to 31.64% in 2023, then surged by 225 bps to 39.47% in 2024, then slipped by 13 bps to 34.34% in 2025, then advanced by 6 bps to 36.48% in 2026.
• Per Business Quant, the three latest UTMD EBT Margin figures stand at 36.48% (Q1 2026), 34.34% (Q4 2025), and 33.72% (Q3 2025).